Home Ingredients D-Mannose
Kidney/Urinary TractWomen's Health

D-Mannose

Evidence Level
Moderate
3 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

D-Mannose is a simple sugar closely related to glucose, found naturally in fruits such as cranberries, peaches, and apples. Although chemically a monosaccharide, only a small fraction is metabolized for energy — most is excreted unchanged in the urine, where it can bind to type 1 fimbriae of uropathogenic Escherichia coli and help prevent the bacteria from adhering to the bladder wall. This anti-adhesion mechanism has made D-mannose a popular non-antibiotic option for women with recurrent urinary tract infections. The evidence base includes a landmark 2014 randomized trial, several smaller positive studies, and a larger 2024 UK primary-care merit trial that did not find benefit over placebo — making the overall picture mixed but clinically meaningful for some users.

Studied Dose 2 g once daily for prophylaxis (most studied); 1.5-3 g daily in symptomatic protocols, dissolved in water.
Active Compound D-Mannose, a six-carbon monosaccharide (C6H12O6) and C2 epimer of glucose, typically supplied as 95-100% pure powder or capsules.

Benefits

Helps Support Urinary Tract Health

D-mannose helps support a healthy urinary environment by binding to E. coli fimbriae in the urine, which may help reduce the bacteria's ability to attach to the bladder wall — a key mechanism in recurrent urinary tract concerns.

Supported by Trial 2, Trial 3

Non-Antibiotic Daily Option

For women looking to reduce reliance on long-term antibiotic prophylaxis, D-mannose offers a non-antibiotic, sugar-based option that has been evaluated in randomized trials with a strong tolerability profile.

Supported by Trial 1, Trial 3

Generally Well-Tolerated Daily Use

Even at gram-level daily doses for six months in clinical work, D-mannose has shown a favorable safety profile, with only mild GI effects reported and no meaningful impact on blood glucose in non-diabetic adults.

Supported by Trial 1, Trial 2

Convenient Powder Format

D-mannose dissolves readily in water with a slightly sweet taste, making it easy to take consistently — convenience is a significant factor in real-world adherence to UTI-prevention regimens.

Supported by Trial 1, Trial 2

Mechanism of action

1

FimH Anti-Adhesion in the Bladder

Uropathogenic E. coli use the FimH adhesin on type 1 fimbriae to bind mannosylated receptors on the urothelium. Excreted urinary D-mannose saturates FimH, helping flush bacteria out during urination rather than allowing colonization.

2

Minimal Systemic Metabolism

Only a small fraction of ingested D-mannose is metabolized; the majority is filtered by the kidneys and concentrated in the urine, where it can interact with bacterial adhesins at meaningful local concentrations.

3

No Direct Antibacterial Action

D-mannose does not kill bacteria — it works mechanically by preventing attachment. This avoids antimicrobial selection pressure and theoretically limits resistance development.

Clinical trials

1
D-Mannose vs Nitrofurantoin Prophylaxis

Open-label randomized trial; 2 g D-mannose/day vs 50 mg nitrofurantoin/day vs no prophylaxis for 6 months

308 women with history of recurrent UTI

Six-month UTI recurrence was significantly lower in both the D-mannose and antibiotic arms than in no-prophylaxis controls, with D-mannose showing fewer adverse events than the antibiotic — supporting its use as a non-antibiotic prevention option.

2
D-Mannose Pilot in Acute Cystitis

Open-label pilot study; 1.5 g D-mannose daily for acute cystitis treatment plus extended follow-up

45 women with acute, uncomplicated cystitis

D-mannose was associated with reductions in lower urinary tract symptoms and a lower rate of UTI recurrence over six-month follow-up; a hypothesis-generating pilot rather than a definitive trial.

3
Merit Trial: D-Mannose for Prevention in UK Primary Care

Pragmatic, double-blind, placebo-controlled RCT; 2 g D-mannose daily vs placebo for 6 months

598 women presenting to UK primary care with recurrent UTI (mean age 58)

Daily D-mannose did not significantly reduce the proportion of women experiencing a subsequent clinically suspected UTI compared with placebo; trial authors concluded D-mannose should not be routinely recommended for primary-care prophylaxis in this group.

Side effects and drug interactions

Common Potential side effects

Mild diarrhea or loose stools can occur, particularly at higher gram-level doses.
Bloating or abdominal discomfort is occasionally reported.
Theoretical caution in poorly controlled diabetes due to the sugar load.
Not a substitute for antibiotic therapy in established, symptomatic infection.

Important Drug interactions

No major drug-drug interactions are well documented for D-mannose.
May affect glycemic monitoring slightly in people with diabetes.
Discuss with a clinician before substituting for prescribed UTI prophylaxis.

Featured in these supplement guides

Bladder Control & Urinary Health→

More Kidney/Urinary Tract Ingredients

Kidney/Urinary Tract
Exocyan™ (Cranberry Extract for UTI)
Exocyan™ is Nexira's (France) standardized cranberry extract (Vaccinium macrocarpon) — dis…
Kidney/Urinary Tract
Pacran® (Whole Cranberry Fruit Powder — Givaudan/Naturex)
Pacran is a branded whole-fruit cranberry powder from Givaudan (formerly Naturex), deliver…
Kidney/Urinary Tract
Flowens™ (Cranberry for Men's & Women's Urological Health — Givaudan)
Flowens™ is Givaudan's (formerly Naturex) standardized whole-fruit cranberry ingredient (V…
Kidney/Urinary Tract
MannoHealth™ (D-Mannose — Bioenergy Life Science)
MannoHealth™ is Bioenergy Life Science's branded high-purity D-mannose — distinguished as…

Related articles from our blog

📝 Article
Supplements for UTIs: What Actually Helps Prevent Them
If you have ever felt a UTI coming on and reached for cranberry pills, this guide is the honest version of what those su…

Frequently asked questions about D-Mannose

What is D-mannose used for?

D-mannose is a simple sugar used for urinary tract health, particularly preventing recurrent UTIs caused by E. coli. It works by binding to E. coli bacteria so they are flushed out in urine rather than sticking to the bladder.

Does D-mannose help with UTIs?

D-mannose has research suggesting it may help prevent recurrent E. coli UTIs, with some studies showing benefit comparable to low-dose antibiotics for prevention. It is not a substitute for treating an active infection, which needs medical care.

How much D-mannose should I take?

Prevention studies commonly use about 2 grams per day; for acute prevention at onset, some use 1.5 to 2 grams two to three times daily for a few days. Take it with plenty of water. Follow product labeling.

Is D-mannose safe?

D-mannose is generally very well tolerated; high doses may cause loose stools or bloating. Because it is a sugar, people with diabetes should monitor blood sugar, though little is metabolized. See a doctor for an active or worsening UTI.

What is D-Mannose?

D-Mannose is a simple sugar closely related to glucose, found naturally in fruits such as cranberries, peaches, and apples. Although chemically a monosaccharide, only a small fraction is metabolized for energy — most is excreted unchanged in the urine, where it can bind to type 1 fimbriae of uropathogenic Escherichia c…

What is the recommended dosage of D-Mannose?

The clinically studied dose is 2 g once daily for prophylaxis (most studied); 1.5-3 g daily in symptomatic protocols, dissolved in water. Always follow the product label and check with a healthcare provider for personal advice.

Is D-Mannose safe, and does it have side effects?

For most healthy adults, D-Mannose is well tolerated at studied doses. Reported effects can include: Mild diarrhea or loose stools can occur, particularly at higher gram-level doses. Bloating or abdominal discomfort is occasionally reported. It may also interact with some medications. D-Mannose is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does D-Mannose interact with any medications?

Possible interactions include: No major drug-drug interactions are well documented for D-mannose. May affect glycemic monitoring slightly in people with diabetes. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for D-Mannose?

NutraSmarts rates the evidence for D-Mannose as Moderate (3 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79-84. doi: 10.1007/s00345-013-1091-6.PubMedUsed to support: Open-label RCT of 308 women showing 2 g/day D-mannose reduced 6-month UTI recurrence comparably to nitrofurantoin and significantly better than no prophylaxis.
  2. Domenici L, Monti M, Bracchi C, et al. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920-5.PubMedUsed to support: Open-label pilot in 45 women showing D-mannose reduced lower urinary tract symptoms and UTI recurrence over 6-month follow-up.
  3. Hayward G, Mort S, Hay AD, et al. d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern Med. 2024;184(6):619-628. doi: 10.1001/jamainternmed.2024.0264.PubMedUsed to support: Pragmatic 598-woman UK primary-care RCT (merit) in which daily 2 g D-mannose did not reduce clinically suspected UTI compared with placebo over 6 months.